ATLANTA (October 1, 2009) — A group of Smith, Gambrell & Russell attorneys assisted client Sanuwave, Inc. in the completion of a reverse merger with a wholly-owned subsidiary of Rub Music Enterprises, Inc., making Sanuwave the subsidiary of a publicly traded company effective September 25, 2009.
John Ethridge was lead counsel. Terry Schwartz, Toni Burgess and Emily Cacioppo were also part of the SGR team.
Sanuwave is an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area. The company intends to apply its proprietary Pulsed Acoustic Cellular Expression (“PACETM”) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. It is developing a platform of products that activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration.
As of September 25, 2009, RME had $3.3 million of cash and cash equivalents. The executive officers and directors of Sanuwave became the executive officers and directors of RME upon the closing of the reverse merger.